Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Darexaban

Refine Results

Search results

  • RSS Feed
(1 - 1 of 1)
RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome